Tenascin: A potential role in human arteriovenous PTFE graft failure

Journal of Surgical Research

Volumn 60, Issue 2, 1996, Pages 409-416

  Chen, Changyi ^a   Ku, David N ^a   Kikeri, Deepak ^a   Lumsden, Alan B ^a  

^a Box M 11 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; POLITEF; TENASCIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL GRAFT; CELL PROLIFERATION; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MALE; NEOVASCULARIZATION (PATHOLOGY); POLITEF IMPLANT; PRIORITY JOURNAL;

EID: 0030026766     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0067     Document Type: Conference Paper

References (35)

1. Swedberg, S. H., Brown, B. G., Sigley, R., Wight, T. N., Gordon, D., and Nicholls, S. C. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80: 1726, 1989.
2. Tordoir, J. H., Herman, J. M., Kwan, T. S., and Diderich, P. M. Long-term follow-up of the polytetrafluoroethylene (PTFE) prosthesis as an arteriovenous fistula for hemodialysis. Eur. J. Vasc. Surg. 2: 3, 1988.
3. Scottiurai, V. S. Biogenesis and etiology of distal anastomotic intimal hyperplasia. Int. Angiol. 9: 59, 1990.
4. Connolly, J. E., Brownell, D. A., Levine, E. F., and McCart, P. M. Complications of renal dialysis access procedures. Arch. Surg. 119: 1325, 1984.
5. Choi, E. T., Schgal, N. L., Ryan, U. S., and Callow, A. D. Blocking type I collagen formation prevents smooth muscle cell proliferation by causing late G1 cell cycle arrest. Surg. Forum 45: 353, 1994.
6. Schuppan, D., Somasundaram, R., Dieterich, W., Ehnis, T., and Bauer, M. The extracellular matrix in cellular proliferation and differentiation. Ann. NY Acad. Sci. 733: 87, 1994.
7. Erickson, H. P., and Inghesias, J. L. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 311: 267, 1984.
8. Inaguma, Y., Kusakabe, M., Mackie, E. J., Pearson, C. A., Chiquet-Ehrismann, R., and Sakakura, T. Epithelial induction of stromal tenascin in the mouse mammary gland: From embryogenesis to carcinogenesis. Dev. Biol. 128: 245, 1988.
9. Steindler, D. A., Cooper, N. G. F., Faissner, A., and Schachner, M. Boundaries defined by adhesion molecules during development of the cerebellar cortex: The J1/tenascin glycoprotein in the mouse somatosensory cortex barrel field. Dev. Biol. 131: 243, 1989.
10. Mackie, E. J., Chiquet-Ehrismann, R., Pearson, C. A., Inaguma, Y., Taya, K., Taya, K., Kawarada, Y., and Sakakura, T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Natl. Acad. Sci. USA 84: 4621, 1987.
11. Hedin, U., Holm, J., and Hansson, G. Induction of tenascin in rat arterial injury: Relationship to altered smooth muscle cell phenotype. Am. J. Pathol. 139: 649, 1991.
12. Chen, C., Suwyn, C., Mattar, S. G., Coyle, K., Ku, D. N., and Lumsden, A. B. Distribution of tenascin in human neointimal hyperplastic lesions. Surg. Forum 45: 382, 1994.
13. Rekhter, M., Nicholls, S., Ferguson, M., and Gordon, D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler. Thromb. 13: 609, 1993.
14. Soini, Y., Kamel, D., Apaja-Sarkkinen, M., Virtanen, I., and Lethto, V. P. Tenascin immunoreactivity in normal and pathological bone marrow. J. Clin. Pathol. 46: 218, 1993.
15. Schwartz, R. S., Holmes, D. R., and Topol, E. J. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol. 20: 1284, 1992.
16. Dobrin, P. B., Littoy, F. N., and Endeon, E. D. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 105: 393, 1989.
17. LoGerfo, F. W., Soncrant, T., Teel, T., and Dewey, F., Jr. Boundary layer separation in models of side to end arterial anastomoses. Arch. Surg. 114: 1369, 1979.
18. McGeachie, J., Campbell, P., and Prendergast, F. J. Vein-to-artery grafts: The long-term development of neointimal hyperplasia and its relationship to vasa vasorum and sympathetic innervation. Aust. NZ J. Surg. 59: 59, 1989.
19. Lumsden, A. B., Chen, C., and Ku, D. N. Neovascularization in the venous neointimal hyperplastic lesions of arteriovenous grafts. J. Am. Soc. Nephrol. 5: 421, 1994.
20. Fuster, V., Badimon, L., Badimon, J. J., and Chesebro, J. H. The pathogenesis of coronary artery disease and the acute coronary syndrome (I). N. Engl. J. Med. 326: 242, 1992.
21. Lindner, V., Majack, R. A., and Reidy, M. A. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J. Clin. Invest. 85: 2004, 1990.
22. Majesky, M. W., Lindner, V., Twardzik, D. R., Schwartz, S. M., and Reidy, M. A. Production of transforming growth factor beta 1 during repair of arterial injury. J. Clin. Invest. 88: 904, 1991.
23. Jawien, A., Bowen-Pope, D. F., Lindner, V., Schwartz, S. M., and Clowes, A. M. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89: 507, 1992.
24. Thyberg, J., Hedin, U., Sjolund, M., Palmgerg, L., and Botger, B. A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10: 966, 1990.
25. Chen, C., Allen, R. C., Jaffe, M. B., and Lumsden, A. B. Quantitative study of neointimal hyperplasia in a canine model of arteriovenous polytetrafluoroethylene grafts. Presented at The 5th Annual Winter Meeting of the Peripheral Vascular Surgery Society, Breckenridge, Colorado, Jan. 27-29, 1995.
26. Mackie, E. J., Tucker, R. P., Halfter, W., Chiquet-Ehrismann, R., and Epperlein, H. H. The distribution of tenascin coincides with pathways of neural crest cell migration. Development 102: 237, 1988.
27. Riou, J. F., Shi, D. L., Chiquet, M., and Boucaut, J. C. Expression of tenascin in response to neural induction in amphibian embryos. Development 104: 511, 1989.
28. Hoffman, S., Crossin, K. L., Prediger, E. A., Cunningham, B. A., and Edelman, G. M. Expression and function of cell-adhesion molecules during the early development of the heart. Ann. NY Acad. Sci. 588: 73, 1990.
29. Garcia-Martinez, V., Sanchez-Quintana, D., and Hurle, J. M. Histogenesis of semilunar valves: An immunohistochemical analysis of tenascin and type-I collagen distribution in developing chick heart valves. Cell Tissue Res. 259: 299, 1990.
30. Mackie, E. L., Scott-Burden, T., Hahn, A. W., Regenass, S., Weller, A., and Buhler, F. R. Expression of tenascin by vascular smooth muscle cells: Alterations in hypertensive rats and stimulation by angiotensin II. Am. J. Pathol. 141: 377, 1992.
31. Salmivirta, M., Elenius, K., Vainio, S., Hofer, U., Chiquet-Ehrismann, R., Thesleff, I., and Jalkanen, M. Syndecan from embryonic tooth mesenchyme binds tenascin. J. Biol. Chem. 266: 7733, 1991.
32. Mackie, E. J., Halfter, W., and Liverani, D. Induction of tenascin in healing wounds. J. Cell. Biol. 107: 2757, 1988.
33. Ferguson, J. E., Schor, A. M., and Ferguson, M. W. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation 42:199, 1990.
34. End, P., Panayotou, G., Entwistle, A., Waterfield, M. D., and Chiquet, M. Tenascin: A modulator of cell growth. Eur. J. Biochem. 209: 1041, 1992.
35. Chen, C., Mattar, S. G., Allen, R. C., Noe, B., and Lumsden, A. B. Tenascin distribution and cell proliferation in the early stage of arteriovenous loop graft. J. Am. Soc. Nephrol. 5: 411, 1994.